Dr. David Kamp, MD

• Pulmonary Disease

• Critical Care Medicine

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Northwestern University Mcgaw Mc

  Fellowship Hospital, 1987

• Northwestern University Mcgaw Mc

  Residency Hospital, 1984

• Mcgaw Medical Center Of Northwestern University|northwestern University Mcgaw Mc

  Internship Hospital, 1982

• Wayne State University School Of Medicine

  Medical School, 1981

• English

• Dutch

• Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage, 2016-11-11

• The Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary Fibrosis, 2015-09-07

• Lipid Mediators Regulate Pulmonary Fibrosis: Potential Mechanisms and Signaling Pathways, 2020-06-15

• Warranting Investigation of Primary Lung Adenocarcinoma in Patients With an Extrapulmonary Malignancy and Lung Nodules Due to High Frequency, 2016-02-12

• PULMONARY COMPLICATIONS OF TUMOR NECROSIS FACTOR-TARGETED THERAPY, 2009-02-07

• Oxidative Stress and Pulmonary Fibrosis, 2012-12-05

• Proteasomal inhibition after injury prevents fibrosis by modulating TGF-ß1signalling, 2011-09-15

• Molecular Basis of Asbestos-Induced Lung Disease, 2013-01-24

• SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis, 2016-10-06

• SIRT3 Overexpression Ameliorates Asbestos-Induced Pulmonary Fibrosis, mt-DNA Damage, and Lung Fibrogenic Monocyte Recruitment, 2021-06-25

• Long Noncoding RNAFENDRRInhibits Lung Fibroblast Proliferation via a Reduction of ß-Catenin, 2021-08-09

• The Sphingosine Kinase 1 Inhibitor, PF543, Mitigates Pulmonary Fibrosis by Reducing Lung Epithelial Cell mtDNA Damage and Recruitment of Fibrogenic Monocytes, 2020-08-05